Results 81 to 90 of about 4,707 (174)
Evaluating the Safety of Tenecteplase Versus Alteplase for Acute Ischemic Stroke
Background/Objectives: This study aims to compare the safety of tenecteplase versus alteplase for acute ischemic stroke. Methods: This was a multicenter, retrospective cohort study including 11 Memorial Hermann Health System hospitals in Houston from 7 ...
Salma Guerrero Miranda +4 more
doaj +1 more source
One bolus, many benefits: implementing tenecteplase for acute ischemic stroke
Presented at the Midyear Clinical Meeting. Overall, no statistically significant differences in door-to-needle time or secondary outcomes between alteplase and tenecteplase groups was identified.
Beckett, Robert D, PharmD
core
A study of retinal penetration of intravitreal tenecteplase in pigs
PURPOSE.
Kwan, Anthony S. L. +4 more
core +1 more source
BackgroundThe optimal reperfusion approach for acute ischemic stroke (AIS) due to large vessel occlusion (LVO) remains under debate. While endovascular thrombectomy (EVT) is the standard treatment, the role of intravenous thrombolysis before EVT ...
Wenkui Li +8 more
doaj +1 more source
Background Tenecteplase, a modified plasminogen activator with higher fibrin specificity and longer half-life, may have advantages over alteplase in acute ischemic stroke thrombolysis.
Levi, Christopher (R19066) +21 more
core +1 more source
Tenecteplase in large-vessel occlusion with or without thrombectomy: a meta-analysis
BackgroundDespite the growing adoption of Tenecteplase for stroke thrombolysis, key questions such as the role of bridging therapy and extended-window use in large-vessel occlusion (LVO) patients with or without access to endovascular thrombectomy (EVT ...
Ahmed Alkhiri +9 more
doaj +1 more source
Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report [PDF]
Cuicui Liu, Junyan Liu, Huiling Ren, Yuzhu Xu, Wanhu Liu Department of Neurology, The Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Wanhu Liu, Department of Neurology, The Third Hospital of Hebei ...
Ren H, Liu J, Liu C, Xu Y, Liu W
core
Background: Tenecteplase is used as an alternative to alteplase and is considered noninferior for thrombolysis in acute ischemic stroke. Objectives: To compare the effectiveness and adverse effects of tenecteplase and alteplase in the real-world ...
Arpan Dutta +14 more
doaj +1 more source

